News

Webcast Image Webcast
Q4 2020 IRIDEX Earnings Conference Call
03/22/21 at 5:00 PM EDT

Webcast Image Webcast
Q1 2021 IRIDEX Earnings Conference Call
05/11/21 at 5:00 PM EDT

Date Title Teaser
05/11/21
Summary ToggleIridex Announces First Quarter 2021 Financial Results MOUNTAIN VIEW, Calif. , May 11, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended April 3, 2021 . First Quarter Highlights Closed strategic collaboration with Topcon Corporation netting $19.5 million in new funds Record first
04/27/21
Summary ToggleIridex to Report First Quarter 2021 Financial Results on May 11, 2021 MOUNTAIN VIEW, Calif. , April 27, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation  (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the first quarter of
03/22/21
Summary ToggleIridex Announces Fourth Quarter and Full Year 2020 Financial Results MOUNTAIN VIEW, Calif. , March 22, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and year ended January 2, 2021 . Fourth Quarter Highlights Total revenue in the fourth quarter increased 5% to $12.3 million year-over-year Sold
03/10/21
Summary ToggleIridex Completes Transaction with Topcon Corporation MOUNTAIN VIEW, Calif. , March 10, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that it has completed the previously announced transaction with Topcon
03/08/21
Summary ToggleIridex to Report Fourth Quarter and Full Year 2020 Financial Results on March 22, 2021 MOUNTAIN VIEW, Calif. , March 08, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation  (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the fourth quarter and
03/02/21
Summary ToggleIridex Announces Strategic Collaboration with Topcon Corporation Transaction provides $19.5 million cash to Iridex , as two leaders join forces in glaucoma and  retinal disease treatment Iridex to host a conference call presentation on March 2, 2021 at 2:00 p.m. PT / 5:00 p.m. ET MOUNTAIN VIEW, Calif. , March 02, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation
01/11/21
Summary ToggleIRIDEX Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2020 MOUNTAIN VIEW, Calif. , Jan. 11, 2021 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today provided preliminary unaudited operational and financial results for the fourth quarter and full year ended January 2, 2021 . Fourth Quarter 2020 Total revenue expected to be $12.2 million to $12.4
logo aa0 logo ags logo ascrs logo asrs logo esrs0 logo euretina